STS Summer Series: Controversial Cases in Mitral Disease–Surgical and Transcatheter Treatments

Mitral valve disease is one of the most common valvular heart defects. For patients with high perioperative risk and older age prohibitive for valve surgery, the development of transcatheter mitral valve therapies offers new options. In this episode of the STS Summer Series, Gorav Ailawadi, MD, MBA, Tsuyoshi Kaneko, MD, and an expert panel discuss transcatheter versus surgical treatments for complex cases, including:

  • Degenerative mitral regurgitation
  • Functional mitral valve regurgitation
  • Mitral annular calcification
  • Failed bioprosthetic mitral valve

This episode is also available as a podcast.

This series is supported by Medtronic.

Gorav Ailawadi, MD, MBA
Michigan Medicine
Ann Arbor, MI

Tsuyoshi Kaneko, MD
Harvard Medical School, Brigham and Women’s Hospital
Boston, MA

Vinay Badhwar, MD
West Virginia University Heart and Vascular Institute
Morgantown, WV

Mayra Guerrero, MD
Mayo Clinic
Rochester, MN

Robert L. Smith II, MD
Baylor Scott & White Health
Plano, TX

Paul Sorajja, MD
Minneapolis Heart Institute
Minneapolis, MN

Gilbert H. Tang, MD, MSc, MBA
Mount Sinai Health System
New York, NY

Dee Dee Wang, MD
Henry Ford Health System
Detroit, MI